Symmetry Investments LP Curis Inc Transaction History

Symmetry Investments LP

  • $892 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$2.31 - $5.13 $43,737 - $97,131
-18,934 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$4.45 - $8.09 $84,256 - $153,176
18,934 New
18,934 $90,000

About CURIS INC

CRIS Quotes by TradingView
  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Symmetry Investments LP Portfolio

Follow Symmetry Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Symmetry Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Symmetry Investments LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email